Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 278

1.

Doppler gradients, valve area and ventricular function in pregnant women with aortic or pulmonary valve disease: Left versus right.

Siegmund AS, Pieper PG, Mulder BJM, Sieswerda GT, van Dijk APJ, Roos-Hesselink JW, Jongbloed MRM, Konings TC, Bouma BJ, Groen H, Sollie-Szarynska KM, Kampman MAM, Bilardo CM, van Veldhuisen DJ, Aalberts JJJ.

Int J Cardiol. 2019 Nov 16. pii: S0167-5273(18)36330-7. doi: 10.1016/j.ijcard.2019.11.118. [Epub ahead of print]

PMID:
31785953
2.

Risk of coronary artery disease in adults with congenital heart disease: A comparison with the general population.

Kuijpers JM, Vaartjes I, Bokma JP, van Melle JP, Sieswerda GT, Konings TC, Boo MB, van der Bilt I, Voogel B, Zwinderman AH, Mulder BJM, Bouma BJ.

Int J Cardiol. 2019 Nov 18. pii: S0167-5273(19)32104-7. doi: 10.1016/j.ijcard.2019.11.114. [Epub ahead of print]

PMID:
31767384
3.

Advantages of mobile health in the management of adult patients with congenital heart disease.

Kauw D, Koole MAC, Winter MM, Dohmen DAJ, Tulevski II, Blok S, Somsen GA, Schijven MP, Vriend JWJ, Robbers-Visser D, Mulder BJM, Bouma BJ, Schuuring MJ.

Int J Med Inform. 2019 Dec;132:104011. doi: 10.1016/j.ijmedinf.2019.104011. Epub 2019 Oct 15.

4.

Non-Vitamin K Antagonist Oral Anticoagulants in Adult Congenital Heart Disease.

Mongeon FP, Macle L, Beauchesne LM, Bouma BJ, Schwerzmann M, Mulder BJM, Khairy P.

Can J Cardiol. 2019 Jun 26. pii: S0828-282X(19)30443-X. doi: 10.1016/j.cjca.2019.06.022. [Epub ahead of print] Review.

PMID:
31635950
5.

Prolonged Tpeak -Tend interval is a risk factor for sudden cardiac death in adults with congenital heart disease.

Vehmeijer JT, Koyak Z, Vink AS, Budts W, Harris L, Silversides CK, Oechslin EN, Zwinderman AH, Mulder BJM, de Groot JR.

Congenit Heart Dis. 2019 Oct 1. doi: 10.1111/chd.12847. [Epub ahead of print]

PMID:
31573144
6.

Learning strategies among adult CHD fellows.

Bokma JP, Daily JA, Kovacs AH, Oechslin EN, Baumgartner H, Khairy P, Mulder BJM, Veldtman GR.

Cardiol Young. 2019 Nov;29(11):1356-1360. doi: 10.1017/S1047951119002063. Epub 2019 Sep 10.

PMID:
31502529
7.

Medium-term systemic blood pressure after stenting of aortic coarctation: a systematic review and meta-analysis.

Meijs TA, Warmerdam EG, Slieker MG, Krings GJ, Molenschot MMC, Meijboom FJ, Sieswerda GT, Doevendans PA, Bouma BJ, de Winter RJ, Mulder BJM, Voskuil M.

Heart. 2019 Oct;105(19):1464-1470. doi: 10.1136/heartjnl-2019-314965. Epub 2019 Jul 17.

PMID:
31315937
8.

Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients.

Yin 殷晓科 X, Wanga S, Fellows AL, Barallobre-Barreiro J, Lu R, Davaapil H, Franken R, Fava M, Baig F, Skroblin P, Xing Q, Koolbergen DR, Groenink M, Zwinderman AH, Balm R, de Vries CJM, Mulder BJM, Viner R, Jahangiri M, Reinhardt DP, Sinha S, de Waard V, Mayr M.

Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1859-1873. doi: 10.1161/ATVBAHA.118.312175. Epub 2019 Jul 18.

9.

Progression of aortic root dilatation and aortic valve regurgitation after the arterial switch operation.

van der Palen RLF, van der Bom T, Dekker A, Tsonaka R, van Geloven N, Kuipers IM, Konings TC, Rammeloo LAJ, Ten Harkel ADJ, Jongbloed MRM, Koolbergen DR, Mulder BJM, Hazekamp MG, Blom NA.

Heart. 2019 Nov;105(22):1732-1740. doi: 10.1136/heartjnl-2019-315157. Epub 2019 Jul 10.

10.

Aortic Root Geometric and Dynamic Changes After Device Closure of Interatrial Shunts.

Abdelghani M, Nassif M, de Bruin-Bon RHACM, Al-Amin AM, El-Baz MS, El-Shedoudy SAO, Mulder BJM, de Winter RJ, Bouma BJ.

J Am Soc Echocardiogr. 2019 Aug;32(8):1016-1026.e5. doi: 10.1016/j.echo.2019.03.022. Epub 2019 May 17.

PMID:
31109742
11.

Impact of atrial septal defect closure on diffusing capacity for nitric oxide and carbon monoxide.

Nassif M, van Steenwijk RP, van der Lee I, Sterk PJ, de Jongh FHC, Hogenhout JM, Tijssen JGP, Mulder BJM, de Winter RJ.

ERJ Open Res. 2019 Apr 8;5(2). pii: 00260-2018. doi: 10.1183/23120541.00260-2018. eCollection 2019 Apr.

12.

The Natural and Unnatural History of Congenital Aortic Arch Abnormalities Evaluated in an Adult Survival Cohort.

Lodeweges JE, Dikkers FG, Mulder BJM, Roos-Hesselink JW, Vliegen HW, van Dijk APJ, Sieswerda GT, Konings TC, Berger RMF, Slebos DJ, Ebels T, van Melle JP.

Can J Cardiol. 2019 Apr;35(4):438-445. doi: 10.1016/j.cjca.2018.12.004. Epub 2018 Dec 7.

PMID:
30935634
13.

High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality.

Woudstra OI, Kuijpers JM, Meijboom FJ, Post MC, Jongbloed MRM, Duijnhouwer AL, van Dijk APJ, van Melle JP, Konings TC, Zwinderman AH, Mulder BJM, Bouma BJ.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):216-225. doi: 10.1093/ehjcvp/pvz014.

14.

Electrical remodeling after percutaneous atrial septal defect closure in pediatric and adult patients.

Kamphuis VP, Nassif M, Man SC, Swenne CA, Kors JA, Vink AS, Ten Harkel ADJ, Maan AC, Mulder BJM, de Winter RJ, Blom NA.

Int J Cardiol. 2019 Jun 15;285:32-39. doi: 10.1016/j.ijcard.2019.02.020. Epub 2019 Feb 23.

15.

The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients⁻Insights from Rodent-Based Animal Studies.

van Andel MM, Groenink M, Zwinderman AH, Mulder BJM, de Waard V.

Int J Mol Sci. 2019 Mar 5;20(5). pii: E1122. doi: 10.3390/ijms20051122. Review.

16.

Pregnancy in women with pre-existent ischaemic heart disease: a systematic review with individualised patient data.

Lameijer H, Burchill LJ, Baris L, Ruys TP, Roos-Hesselink JW, Mulder BJM, Silversides CK, van Veldhuisen DJ, Pieper PG.

Heart. 2019 Jun;105(11):873-880. doi: 10.1136/heartjnl-2018-314364. Epub 2019 Feb 21. Review.

PMID:
30792240
17.

Identifying pathogenic variants in the Follistatin-like 1 gene (FSTL1) in patients with skeletal and atrioventricular valve disorders.

Prakash S, Mattiotti A, Sylva M, Mulder BJM, Postma AV, van den Hoff MJB.

Mol Genet Genomic Med. 2019 Apr;7(4):e00567. doi: 10.1002/mgg3.567. Epub 2019 Feb 5.

18.

Education as important predictor for successful employment in adults with congenital heart disease worldwide.

Sluman MA, Apers S, Sluiter JK, Nieuwenhuijsen K, Moons P, Luyckx K, Kovacs AH, Thomet C, Budts W, Enomoto J, Yang HL, Jackson JL, Khairy P, Cook SC, Subramanyan R, Alday L, Eriksen K, Dellborg M, Berghammer M, Mattsson E, Mackie AS, Menahem S, Caruana M, Gosney K, Soufi A, Fernandes SM, White KS, Callus E, Kutty S, Bouma BJ, Mulder BJM; APPROACH-IS consortium, the International Society for Adult Congenital Heart Disease (ISACHD).

Congenit Heart Dis. 2019 May;14(3):362-371. doi: 10.1111/chd.12747. Epub 2019 Feb 4.

19.

Safety and effectiveness of home-based, self-selected exercise training in symptomatic adults with congenital heart disease: A prospective, randomised, controlled trial.

van Dissel AC, Blok IM, Hooglugt JQ, de Haan FH, Jørstad HT, Mulder BJM, Bouma BJ, Winter MM.

Int J Cardiol. 2019 Mar 1;278:59-64. doi: 10.1016/j.ijcard.2018.12.042. Epub 2018 Dec 17.

PMID:
30594347
20.

Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot.

Page DJ, Miossec MJ, Williams SG, Monaghan RM, Fotiou E, Cordell HJ, Sutcliffe L, Topf A, Bourgey M, Bourque G, Eveleigh R, Dunwoodie SL, Winlaw DS, Bhattacharya S, Breckpot J, Devriendt K, Gewillig M, Brook JD, Setchfield KJ, Bu'Lock FA, O'Sullivan J, Stuart G, Bezzina CR, Mulder BJM, Postma AV, Bentham JR, Baron M, Bhaskar SS, Black GC, Newman WG, Hentges KE, Lathrop GM, Santibanez-Koref M, Keavney BD.

Circ Res. 2019 Feb 15;124(4):553-563. doi: 10.1161/CIRCRESAHA.118.313250.

PMID:
30582441

Supplemental Content

Loading ...
Support Center